Vaccinex, Inc.

NASDAQ:VCNX

1.31 (USD) • At close December 23, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016
Revenue 0.570.10.90.050.5230.7240.090.316
Cost of Revenue 00.2070.1690.0020.1991.0330.160.115
Gross Profit 0.57-0.1070.7310.0480.324-0.309-0.070.201
Gross Profit Ratio 1-1.070.8120.960.62-0.427-0.7780.636
Reseach & Development Expenses 16.57413.97917.1621.54925.6722.35316.55116.028
General & Administrative Expenses 6.8816.2026.237.4056.6694.6194.4834.432
Selling & Marketing Expenses 00000000
SG&A 6.8816.2026.237.4056.6694.6194.4834.432
Other Expenses 0-0.1750.043-0.5750.1520.165-0.04-0.004
Operating Expenses 23.45520.00623.3928.37932.33926.97221.03420.46
Operating Income -22.885-19.906-22.49-28.331-32.015-27.281-21.104-20.259
Operating Income Ratio -40.149-199.06-24.989-566.62-61.214-37.681-234.489-64.111
Total Other Income Expenses Net 2.6340.0910.11-0.520.152-2.2372.3456.316
Income Before Tax -20.251-19.815-22.38-28.851-31.863-29.518-18.759-13.943
Income Before Tax Ratio -35.528-198.15-24.867-577.02-60.924-40.771-208.433-44.123
Income Tax Expense 0-0.0930.8520.4580.152-1.8451.2812.986
Net Income -20.251-19.722-23.232-29.309-32.015-29.518-18.722-13.943
Net Income Ratio -35.528-197.22-25.813-586.18-61.214-40.771-208.022-44.123
EPS -43.68-97.59-170.04-327.62-521.95-1,186.7-689.86-526.85
EPS Diluted -43.68-97.59-169.11-327.62-521.95-1,186.7-689.86-526.85
EBITDA -19.748-19.606-21.402-28.055-31.614-28.903-17.195-10.775
EBITDA Ratio -34.646-196.06-24.753-561.1-60.447-37.145-232.644-63.56